Billing and Coding: MolDX: Germline testing for use of PARP inhibitors (A55295) - R12 - Effective October 1, 2025

Date Posted: September 4, 2025

This Billing and Coding article has been revised and published for notice under contract numbers: 02101 (AK), 02201 (ID), 02301 (OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).

Effective Date: October 1, 2025

Summary of Article Changes:

Under ICD-10 Codes that Support Medical Necessity Group 1: Codes added C50.A0, C50.A1, C50.A2, and Z85.4A. This revision is due to the Annual ICD-10-CM Update and will become effective on 10/1/2025.

Under Associated Documents updated Related Local Coverage Documents

Visit the Noridian Active MolDX Billing and Coding Articles and Educational Articles webpage to view the Billing and Coding article or access it via the CMS MCD.

Last Updated Sep 04 , 2025